ARC
BRLI

Absolute Return Capital’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Absolute Return Capital’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-286,739
Closed -$7.32M – 1322
2013
Q4 		$7.32M Buy
286,739
+216,235
+307% +$6.66M 0.08% 280
2013
Q3 		$2.11M Sell
70,504
-53,160
-43% -$1.48M 0.03% 494
2013
Q2 		$3.56M Buy
+123,664
New +$3.41M 0.05% 434

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Absolute Return Capital's BRLI Position: Q1 2014 in Review

Absolute Return Capital sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 286,739 shares — an estimated $7.32M sold.

Absolute Return Capital first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $7.32M in Q4 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • Absolute Return Capital reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • Absolute Return Capital sold 286,739 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $7.32M.
  • Absolute Return Capital first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Absolute Return Capital's BIO-REFERENCE LABS INC-NEW- position peaked at $7.32M in Q4 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Absolute Return Capital's 13F filing for Q1 2014, filed 15 May 2014.